Preservation solutions for liver transplantation in adults: Celsior versus custodiol: A systematic review and meta-analysis with an indirect comparison of randomized trials

Transplantation Proceedings

Volumn 45, Issue 1, 2013, Pages 25-32

  Zuluaga, G L Lema ^a,b   Agudelo, R E Serna ^b   Tobón, J J Zuleta ^a,b  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b HOSPITAL PABLO TOBÓN URIBE   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

CELSIOR; HTK SOLUTION;

ARTICLE; CLINICAL EFFECTIVENESS; FOLLOW UP; GRAFT DYSFUNCTION; GRAFT SURVIVAL; HUMAN; INITIAL POOR FUNCTION; ISCHEMIC TYPE BILIARY LESION; LIVER GRAFT; LIVER PERFUSION; LIVER PRESERVATION; LIVER TRANSPLANTATION; LIVER WEIGHT; META ANALYSIS; PRIMARY DYSFUNCTION; PRIMARY NONFUCTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TREATMENT OUTCOME;

DISACCHARIDES; ELECTROLYTES; GLUCOSE; GLUTAMATES; GLUTATHIONE; GRAFT SURVIVAL; HISTIDINE; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; MANNITOL; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; POTASSIUM CHLORIDE; PROCAINE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK; TIME FACTORS; TREATMENT OUTCOME;

EID: 84873294913     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2012.02.031     Document Type: Article

References (47)

1. F.O. Belzer, J.H. Southard Principles of solid-organ preservation by cold storage Transplantation 45 1988 673
2. A. Jain, J. Reyes, R. Kashyap Long-term survival after liver transplantation in 4,000 consecutive patients at a single center Ann Surg 232 2000 490
3. M. Jimenez, V.S. Turrion, L.G. Alvira Indications and results of retransplantation after a series of 406 consecutive liver transplantations Transplant Proc 34 2002 262
4. C.K. Oh, R.G. Sawyer, S.J. Pelietier Independent predictors for primary non-function after liver transplantation Yonsei Med J 45 2004 1155
5. C. Moreno, A. Sabate, J. Figueras Hemodynamic profile and tissular oxygenation in orthotopic liver transplantation: influence of hepatic artery or portal vein revascularization of the graft Liver Transpl 12 2006 1607
6. R. Adam, P. McMaster, J.G. O'Grady Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry Liver Transpl 9 2003 1231
7. C. Lama, A. Rafecas, J. Figueras Comparative study of Celsior and Belzer solutions for hepatic graft preservation: preliminary results Transplant Proc 34 2002 54
8. C. Moench, K. Moench, A.W. Lohse Prevention of ischemic-type biliary lesions by arterial back-table pressure perfusion Liver Transpl 9 2003 285
9. E. Gnaiger, A.V. Kuznetsov, A. Konigsrainer Autooxidation of glutathione in organ preservation solutions Transplant Proc 32 2000 14
10. B. Ringe, F. Braun, M. Moritz Safety and efficacy of living donor liver preservation with HTK solution Transplant Proc 37 2005 316
11. H.J. Bretschneider Myocardial protection Thorac Cardiovasc Surg 28 1980 295
12. G. Gubernatis, R. Pichlmayr, P. Lamesch HTK-solution (Bretschneider) for human liver transplantation First clinical experiences Langenbecks Arch Chir 375 1990 66
13. T.A. Churchill, K.M. Cheetham, B.J. Fuller Glycolysis and energy metabolism in rat liver during warm and cold ischemia: evidence of an activation of the regulatory enzyme phosphofructokinase Cryobiology 31 1994 441
14. T. Uemura, H.B. Randall, E.Q. Sanchez Liver retransplantation for primary nonfunction: analysis of a 20-year single-center experience Liver Transpl 13 2007 227
15. C. Moench, A. Uhrig, A. Wunsch reliable markers for diagnosis of rejection and inflammation following orthotopic liver transplantation Transplant Proc 33 2001 3293
16. A. Cavallari, U. Cillo, B. Nardo A multicenter pilot prospective study comparing Celsior and University of Wisconsin preserving solutions for use in liver transplantation Liver Transpl 9 2003 814
17. R. Canelo, N.S. Hakim, B. Ringe Experience with hystidine tryptophan ketoglutarate versus University Wisconsin preservation solutions in transplantation Int Surg 88 2003 145
18. J.D. Blankensteijn, O.T. Terpstra Liver preservation: the past and the future Hepatology 13 1991 1235
19. B. Ringe, F. Braun, M. Moritz Safety and efficacy of living donor liver preservation with HTK solution Transplant Proc 37 2005 316
20. F. Muhlbacher, F. Langer, C. Mittermayer Preservation solutions for transplantation Transplant Proc 31 1999 2069
21. P. Menasche, J.L. Termignon, F. Pradier Experimental evaluation of Celsior, a new heart preservation solution Eur J Cardiothorac Surg 8 1994 207
22. A.M. Glenny, D.G. Altman, F. Song indirect comparisons of competing interventions Health Technol Assess 9 2005 1
23. Department of Health and Ageing Guidelines for preparing submissions to the Pharmaceutical Benefits Advisory Committee (version 4.3) 2008. 2008. Therapeutic Goods Administration, Australian Government [cited 14 April 2011] http://www.health.gov.au/
24. G.A. Wells, S.A. Sultan, L. Chen Indirect evidence: indirect treatment comparisons in meta-analysis 2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Ottawa
25. Review Manager (RevMan) version 5.0 (computer program) 2008 Nordic Cochrane Centre, Cochrane Collaboration Copenhagen, Denmark
26. J. Erhard, R. Lange, R. Scherer Comparison of histidine-tryptophan- ketoglutarate (HTK) solution versus University of Wisconsin (UW) solution for organ preservation in human liver transplantation A prospective, randomized study Transpl Int 7 1994 177
27. P. Pedotti, M. Cardillo, P. Rigotti A comparative prospective study of two available solutions for kidney and liver preservation Transplantation 77 2004 1540
28. F.A. García-Gil, J. Arenas, A. Güemes Preservation of the liver graft with Celsior solution Transplant Proc 38 2006 2385
29. M.H. Meine, M.L. Zanotelli, J. Neumann Randomized clinical assay for hepatic grafts preservation with University of Wisconsin or histidine- tryptophan-ketoglutarate solutions in liver transplantation Transplant Proc 38 2006 1872
30. R. Lopez-Andujar, S. Deusa, E. Montalvá Comparative prospective study of two liver graft preservation solutions: University of Wisconsin and Celsior Liver Transpl 15 2009 1709
31. R.J. Ploeg, A.M. D'Alessandro, S.J. Knechtle Risk factors for primary dysfunction after liver transplantation: a multivariate analysis Transplantation 55 1993 807
32. J.P.T. Higgins, D.G. Altman Assessing risk of bias in included studies J.P.T. Higgins, S. Green, Cochrane handbook for systematic reviews of interventions version 5.0.1 (updated September 2008) 2008 The Cochrane Collaboration Oxford, UK
33. B. Nardo, R. Bertelli, R. Montalti Preliminary results of a clinical randomized study comparing Celsior and HTK solutions in liver preservation for transplantation Transplant Proc 37 2005 320
34. H.C. Bucher, G.H. Guyatt, L.E. Griffith The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials J Clin Epidemiol 50 1997 683
35. J.C. Meneu Diaz, E. Vicente, J. Nuño Prospective comparative study of the efficacy of Celsior solution for preservation in clinical liver transplant Transplant Proc 34 2002 49
36. A.W. Avolio, S. Agnes, E. Nure; Comparative evaluation of two perfusion solutions for liver preservation and transplantation Transplant Proc 38 2006 1066
37. R.J. Ploeg Preliminary results of the European Multicenter Study on UW solution in liver transplantation The Study Group Transplant Proc 22 1990 2185
38. R. Montalti, B. Nardo, Bertelli A prospective comparative study between Celsior and University of Wisconsin preserving solution in liver transplantation from elderly donors Transplantation 78 2004 647
39. B. Nardo, F. Catena, G. Cavallari Randomized clinical study comparing UW and Celsior solution in liver preservation for transplantation: preliminary results Transplant Proc 33 2001 870
40. A. Brolese, A. Avolio, S. Mirabeila Prospective randomized multicentre phase III study of liver perfusion with HTK solution compared with UW or Celsior solutions in the setting of liver transplantation Liver Transplantation 14 suppl 1 2008 S246
41. J. Erhard, R. Lange, R. Scherer Comparison of histidin-tryptophan- ketoglutarate (HTK) solution versus University of Wisconsin (UW) solution for organ preservation in human liver transplantation Hepatology 18 1993 729
42. N.A. Cooper, K.S. Khan, T.J. Clark Local anaesthesia for pain control during outpatient hysteroscopy: systematic review and meta-analysis BMJ 340 2010 1130
43. N. Chaillet, A. Dumont Evidence-based strategies for reducing cesarean section rates: a meta-analysis Birth 34 2007 53
44. C. Heidenhain, J. Pratschke, G. Puhi Incidence of and risk factors for ischemic-type biliary lesions following orthotopic liver transplantation Transpl Int 23 2010 14
45. X.N. Feng, X. Xu, S.S. Zheng Current status and perspective of liver preservation solutions Hepatobiliary Pancreat Dis Int 5 2006 490
46. F. Song, D. Altman Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses BMJ 326 2003 1
47. J.P. Ioannidis Indirect comparisons: the mesh and mess of clinical trials Lancet 368 2006 1470